BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/13/2023 2:28:02 PM | Browse: 154 | Download: 434
 |
Received |
|
2023-07-12 03:42 |
|
Peer-Review Started |
|
2023-07-12 03:42 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-08-02 09:11 |
|
Revised |
|
2023-08-05 09:26 |
|
Second Decision |
|
2023-09-18 06:09 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-09-18 06:55 |
|
Articles in Press |
|
2023-09-18 06:55 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-09-20 13:10 |
|
Typeset the Manuscript |
|
2023-09-28 03:07 |
|
Publish the Manuscript Online |
|
2023-10-13 14:28 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Retrospective Study |
| Article Title |
Clinical observation of Guipi decoction combined with escieptidine oxalate tablets in patients with depression
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jia Yu and Feng-Quan Xu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Feng-Quan Xu, MD, Associate Professor, Department of Psychosomatic Medicine, Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine, No. 5 Beixiange, Xicheng District, Beijing 100053, China. qazujm1258@163.com |
| Key Words |
Jiajian Guipi decoction; Esiceptidine oxalate tablets; Depressive disorder; Sleep quality; Traditional Chinese medicine syndromes |
| Core Tip |
The combination of Guipi decoction and escieptidine oxalate tablets showed promising clinical benefits for individuals with depression. In a study involving 80 patients, the experimental group receiving both treatments exhibited significantly lower Traditional Chinese medicine (TCM) syndrome scores compared to the control group. Post-treatment, both groups experienced notable reductions in self-rating depression scale and Hamilton depression rating scale scores, with the experimental group showing greater improvement. The total treatment efficiency was significantly higher in the experimental group. Additionally, both groups demonstrated improved sleep quality based on Pittsburgh sleep quality index scores. The experimental group had a lower incidence of adverse reactions compared to the control group. These findings indicate that the combined therapy effectively reduced TCM syndrome scores, improved depressive symptoms, and enhanced sleep quality in patients with depression. Thus, Guipi decoction combined with escieptidine oxalate tablets demonstrates potential as a safe and effective treatment option for depression, warranting further research and consideration in clinical practice. |
| Publish Date |
2023-10-13 14:28 |
| Citation |
Yu J, Xu FQ. Clinical observation of Guipi decoction combined with escieptidine oxalate tablets in patients with depression. World J Clin Cases 2023; 11(29): 7017-7025 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i29/7017.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i29.7017 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
